Sharon Marsh
Impact in
- Pharmacology top 0.05%
- Pharmacogenetics and Drug Metabolism
- Oncology top 2%
- Drug Transport and Resistance Mechanisms
- Colorectal Cancer Treatments and Studies
Papers in
- Pharmacology 79
- Pharmacogenetics and Drug Metabolism 78
- Oncology 17
- Colorectal Cancer Treatments and Studies 8
- Drug Transport and Resistance Mechanisms 8
- Co-authors
- Howard L. McLeod (68 shared papers)Russ Biagio Altman (7 shared papers)Teri E. Klein (7 shared papers)Caroline F. Thorn (4 shared papers)Connie M. Oshiro (2 shared papers)Tina Hernandez‐Boussard (2 shared papers)Cristi R. King (11 shared papers)Alex Sparreboom (6 shared papers)
- Journals
- Pharmacogenomics (14 papers)Pharmacogenetics and Genomics (7 papers)Clinical Cancer Research (7 papers)Human Molecular Genetics (4 papers)British Journal of Cancer (3 papers)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Sharon Marsh
117 papers receiving 7.1k citations
Sharon Marsh's Hit Papers
Peers
Comparison fields: 5 of 133
- Pharmacology 2.7k
- Oncology 1.5k
- Biomaterials 399
- Cancer Research 305
- Reproductive Medicine 234
Countries citing papers authored by Sharon Marsh
This map shows the geographic impact of Sharon Marsh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sharon Marsh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sharon Marsh more than expected).
Fields of papers citing papers by Sharon Marsh
This network shows the impact of papers produced by Sharon Marsh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sharon Marsh. The network helps show where Sharon Marsh may publish in the future.
Co-authors
The 25 scholars most cited alongside Sharon Marsh, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 117 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Doxorubicin pathways Hit paper breakdown → | 2010 | 1396 |
| 2 | 2002 | 345 | |
| 3 | 2005 | 220 | |
| 4 | Irinotecan pathway genotype analysis to predict pharmacokinetics. | 2003 | 216 |
| 5 | 2007 | 209 | |
| 6 | 2010 | 204 | |
| 7 | 2010 | 187 | |
| 8 | 2004 | 186 | |
| 9 | 1999 | 175 | |
| 10 | 2016 | 173 | |
| 11 | 2001 | 172 | |
| 12 | 2005 | 156 | |
| 13 | 2008 | 149 | |
| 14 | 2006 | 146 | |
| 15 | Methotrexate (MTX) pathway gene polymorphisms and their effects on MTX toxicity in Caucasian and African American patients with rheumatoid arthritis. | 2008 | 140 |
| 16 | 2011 | 123 | |
| 17 | 2010 | 107 | |
| 18 | 1994 | 103 | |
| 19 | 2000 | 99 | |
| 20 | 2004 | 97 |
About Sharon Marsh
Sharon Marsh is a scholar working on Pharmacology, Oncology, Genetics, Molecular Biology and Pathology and Forensic Medicine, having authored 117 papers that have together received 7.4k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (78 papers), Genetic Associations and Epidemiology (12 papers), Colorectal Cancer Treatments and Studies (8 papers), Drug Transport and Resistance Mechanisms (8 papers), Genetic factors in colorectal cancer (7 papers), Cancer therapeutics and mechanisms (4 papers), Genomics and Rare Diseases (4 papers) and Electronic Health Records Systems (4 papers). The work is most often cited by research in Pharmacology (2.7k citations), Oncology (1.5k citations), Biomaterials (399 citations), Cancer Research (305 citations) and Reproductive Medicine (234 citations). Sharon Marsh has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Howard L. McLeod, Russ Biagio Altman, Teri E. Klein, Caroline F. Thorn, Connie M. Oshiro, Tina Hernandez‐Boussard, Cristi R. King, Alex Sparreboom, Jaap Verweij and Ron H.J. Mathijssen. Their work appears in journals such as Pharmacogenomics, Pharmacogenetics and Genomics, Clinical Cancer Research, Human Molecular Genetics and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.